Fisher Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Hold |
|
|||||
|
2025
Q1 | $2.76M | Sell |
|
|||||
|
2024
Q4 | $4.2M | Buy |
|
|||||
|
2024
Q3 | $5.32M | Sell |
|
|||||
|
2024
Q2 | $5.95M | Sell |
|
|||||
|
2024
Q1 | $5.6M | Buy |
|
|||||
|
2023
Q4 | $4.94M | Buy |
|
|||||
|
2023
Q3 | $4.24M | Sell |
|
|||||
|
2023
Q2 | $3.86M | Buy |
|
|||||
|
2023
Q1 | $3.59M | Sell |
|
|||||
|
2022
Q4 | $3.32M | Sell |
|
|||||
|
2022
Q3 | $3.18M | Buy |
|
|||||
|
2022
Q2 | $2.7M | Buy |
|
|||||
|
2022
Q1 | $3.19M | Sell |
|
|||||
|
2021
Q4 | $3.29M | Buy |
|
|||||
|
2021
Q3 | $3.07M | Sell |
|
|||||
|
2021
Q2 | $2.88M | Buy |
|
|||||
|
2021
Q1 | $2.42M | Sell |
|
|||||
|
2020
Q4 | $2.52M | Sell |
|
|||||
|
2020
Q3 | $2.95M | Buy |
|
|||||
|
2020
Q2 | $3.21M | Sell |
|
|||||
|
2020
Q1 | $2.51M | Sell |
|
|||||
|
2019
Q4 | $1.99M | Sell |
|
|||||
|
2019
Q3 | $1.51M | Buy |
|
|||||
|
2019
Q2 | $1.7M | Sell |
|
|||||
|
2019
Q1 | $2.27M | Buy |
|
|||||
|
2018
Q4 | $472K | Sell |
|
|||||
|
2018
Q3 | $516K | Sell |
|
|||||
|
2018
Q2 | $545K | Buy |
|
|||||
|
2018
Q1 | $458K | Sell |
|
|||||
|
2017
Q4 | $551K | Sell |
|
|||||
|
2017
Q3 | $704K | Buy |
|
|||||
|
2017
Q2 | $693K | Buy |
|
|||||
|
2017
Q1 | $312K | Buy |
|
|||||
|
2016
Q4 | $262K | Buy |
|
|||||
|
2016
Q3 | $249K | Buy |
|
|||||
|
2016
Q2 | $230K | Hold |
|
|||||
|
2016
Q1 | $249K | Sell |
|
|||||
|
2015
Q4 | $334K | Buy |
|
|||||
|
2015
Q3 | $234K | Sell |
|
|||||
|
2015
Q2 | $288K | Buy |
|
|||||
|
2015
Q1 | $241K | Buy |
|
|||||
|
2014
Q4 | $215K | Sell |
|
|||||
|
2014
Q3 | $210K | Buy |
|